A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) Adolescent and adult subgroup analysis

A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) : Adolescent and adult subgroup analysis

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 270(2024) vom: 10. Jan., Seite 110400
1. Verfasser: Rao, V Koneti (VerfasserIn)
Weitere Verfasser: Šedivá, Anna, Dalm, Virgil A S H, Plebani, Alessandro, Schuetz, Catharina, Shcherbina, Anna, Trizzino, Antonino, Zharankova, Yulia, Orpia, Alanvin, Kulm, Elaine, Webster, Sharon, Körholz, Julia, Lougaris, Vassilios, Rodina, Yulia, Conlon, Niall, Coulter, Tanya, Bradt, Jason, Relan, Anurag, Uzel, Gulbu
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2025
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Clinical Trial, Phase III Randomized Controlled Trial APDS Adolescents Leniolisib PASLI PI3K Pediatric Subgroups mehr... Class I Phosphatidylinositol 3-Kinases EC 2.7.1.137 PIK3CD protein, human
Online verfügbar Volltext